These beneficial effects were linked to modulation of the CD47/SHP2/SIRPα/SYK/FcγR pathway in tumor-associated macrophages, indicating that PD-L1 may contribute to post-ischemic cardiac repair. The gene discussed is CD274; the disease is neoplasm.